Cargando…

Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials

BACKGROUND: Decisions by leading journals to require trial registration and to make protocols of phase III randomized clinical trials (RCTs) publicly accessible were landmark events in clinical trial reporting. MATERIALS AND METHODS: We identified phase III cancer RCTs published between 2013 and 201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Fei, Guo, Xinmei, Zhang, Sheng, Xue, Hongxi, Chen, Qiang, Hu, Xichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722592/ https://www.ncbi.nlm.nih.gov/pubmed/29228640 http://dx.doi.org/10.18632/oncotarget.21459

Ejemplares similares

2304: Identifying optimal multiple sclerosis (MS)-specific atrophy markers as primary endpoint for Phase II s in progressive MS
por: Azevedo, Christina, et al.
Publicado: (2018)

Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies
por: Liang, Fei, et al.
Publicado: (2017)

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

A Comparison of Methods for Treatment Selection in Seamless Phase II/III Clinical Trials Incorporating Information on Short-Term Endpoints
por: Kunz, Cornelia Ursula, et al.
Publicado: (2015)

A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019)

Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial
por: Chen, Yu-Pei, et al.
Publicado: (2015)

Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer
por: Zhang, Sheng, et al.
Publicado: (2016)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial
por: Hall, Peter, et al.
Publicado: (2015)

Current variables, definitions and endpoints of the European Cardiovascular Magnetic Resonance Registry
por: Wagner, Anja, et al.
Publicado: (2009)

Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study
por: Takeuchi, Tsutomu, et al.
Publicado: (2017)

Fallback tests for co‐primary endpoints
por: Ristl, Robin, et al.
Publicado: (2016)

Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study
por: Morand, Eric F, et al.
Publicado: (2020)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China
por: Ling, Kexin, et al.
Publicado: (2022)

Determination of quasi-primary odors by endpoint detection
por: Xu, Hanxiao, et al.
Publicado: (2021)

Flexible selection of a single treatment incorporating short‐term endpoint information in a phase II/III clinical trial
por: Stallard, Nigel, et al.
Publicado: (2015)

Updating clinical endpoint definitions
por: Hassoun, Paul M., et al.
Publicado: (2013)

Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
por: Yuan, Jiacheng, et al.
Publicado: (2018)

Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor size
por: Marco-Ariño, Nicolas, et al.
Publicado: (2021)

Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints
por: Meyer, Elias Laurin, et al.
Publicado: (2023)

Design of Clinical Trials Evaluating Sedation in Critically Ill Adults Undergoing Mechanical Ventilation: Recommendations From Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research (SCEPTER) Recommendation III
por: Ward, Denham S., et al.
Publicado: (2021)

Endpoint of the 4-D finite temperature electroweak phase transition
por: Csikor, Ferenc, et al.
Publicado: (1998)

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
por: Wang, Zi-Xian, et al.
Publicado: (2021)

Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization
por: Peterson, Ross L., et al.
Publicado: (2019)

A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials
por: Cabarrou, Bastien, et al.
Publicado: (2022)

Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema
por: Hamada, Masafumi, et al.
Publicado: (2018)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

The Keynesian Endpoint
por: Crescenzi, Tony
Publicado: (2010)

Endpoint security
por: Kadrich, Mark
Publicado: (2007)

Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial
por: Lin, Si-Yuan, et al.
Publicado: (2021)

Multi-Toxic Endpoints of the Foodborne Mycotoxins in Nematode Caenorhabditis elegans
por: Yang, Zhendong, et al.
Publicado: (2015)

Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
por: Suh, Chong Hyun, et al.
Publicado: (2020)

Downstream Change of the Primary Endpoint in the ISCHEMIA Trial: the Elephant in the Room
por: Correia, Luis Cláudio Lemos, et al.
Publicado: (2018)

A two-stage design with two co-primary endpoints
por: Song, James X.
Publicado: (2015)

Choosing primary endpoints for clinical trials of health care interventions
por: McLeod, Charlie, et al.
Publicado: (2019)

A potential primary endpoint for clinical trials in glaucoma neuroprotection
por: De Moraes, Carlos Gustavo, et al.
Publicado: (2023)

2091: Evaluating the validity and utility of surrogate endpoints in clinical trials of chronic kidney disease (CKD)
por: Ying, Jian, et al.
Publicado: (2018)

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions
por: Anker, Stefan D., et al.
Publicado: (2022)

Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints
por: Gunawardana, Manjula, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6k9ug2g3d54hg1rushju2j2v5e